Weybosset Research & Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Weybosset Research & Management's AMGN Position: Q4 2024 in Review
Weybosset Research & Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 700 shares — an estimated $226K sold.
Weybosset Research & Management first reported a position in AMGN in Q4 2017 and held it in 23 quarters. The position peaked at $452K in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Weybosset Research & Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Weybosset Research & Management sold 700 Amgen shares in Q4 2024, an estimated $226K.
- Weybosset Research & Management first reported a position in Amgen in Q4 2017 and held it in 23 quarters.
- Weybosset Research & Management's Amgen position peaked at $452K in Q4 2019.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Weybosset Research & Management's 13F filing for Q4 2024, filed 10 Jan 2025.